The Aussie medtech making breakthroughs in durable heart valves

The $5 billion market for valves to treat aortic stenosis, the most common heart valve disease, has the potential to double by 2025.

CEO of Anteris Technologies, Wayne Paterson, was live with the Ausbiz and says the key points of difference for the Anteris valve are the anti-calcification feature and unique design.

This innovation avoids the need for open-heart surgery, reducing the amount of time it requires for a patient to recover.